{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "62def84c-a379-4705-ab35-02bae4417dc2",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n",
      "Attaching package: ‘dplyr’\n",
      "\n",
      "\n",
      "The following object is masked from ‘package:Biobase’:\n",
      "\n",
      "    combine\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:GenomicRanges’:\n",
      "\n",
      "    intersect, setdiff, union\n",
      "\n",
      "\n",
      "The following object is masked from ‘package:GenomeInfoDb’:\n",
      "\n",
      "    intersect\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:IRanges’:\n",
      "\n",
      "    collapse, desc, intersect, setdiff, slice, union\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:S4Vectors’:\n",
      "\n",
      "    first, intersect, rename, setdiff, setequal, union\n",
      "\n",
      "\n",
      "The following object is masked from ‘package:matrixStats’:\n",
      "\n",
      "    count\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:dbplyr’:\n",
      "\n",
      "    ident, sql\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:BiocGenerics’:\n",
      "\n",
      "    combine, intersect, setdiff, union\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:igraph’:\n",
      "\n",
      "    as_data_frame, groups, union\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:stats’:\n",
      "\n",
      "    filter, lag\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:base’:\n",
      "\n",
      "    intersect, setdiff, setequal, union\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "library(hipathia)\n",
    "library(dplyr)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "ab89b5a1-113c-4aa6-8b9c-442d0baf121d",
   "metadata": {},
   "outputs": [],
   "source": [
    "### genes that belong to circuits"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "7b23ec08-bde8-4191-a46d-563b2d0ed4e3",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loaded 146 pathways\n",
      "\n"
     ]
    }
   ],
   "source": [
    "## dataframe for each gene belong to pathway.\n",
    "\n",
    "pathways <- load_pathways(\"hsa\")\n",
    "names_circs <- names(pathways$pathigraphs)\n",
    "# extrac genes from a pathways\n",
    "f_extract_genes <- function(j){\n",
    "\n",
    "\tgenes <- unique(na.omit(unlist(V(getElement(get_element, j))$genesList)))\n",
    "\tgenes_clean <- genes[genes != \"/\" & genes != \"NA\"]\n",
    "\treturn(genes_clean)\n",
    "}\n",
    "\n",
    "# join every genes of every path\n",
    "genes_com <- c()\n",
    "circs_com <- c()\n",
    "df <- c()\n",
    "\n",
    "for (i in 1:length(names_circs)){\n",
    "\tx <- names_circs[i]\n",
    "\tget_element <- getElement(pathways$pathigraphs,x)$effector.subgraphs\n",
    "\n",
    "\tlist_path_genes <- sapply(names(get_element), f_extract_genes)\n",
    "\n",
    "\tgenes <- paste(do.call(c, list_path_genes)) \n",
    "\tcircs <- paste(do.call(c,sapply(1:length(list_path_genes), FUN=function(z) rep(names(list_path_genes)[z], length(list_path_genes[[z]])))))\t\n",
    "\tgenes_com <- c(genes_com, genes)\n",
    "\tcircs_com <- c(circs_com, circs)\t\n",
    "}\n",
    "\n",
    "\n",
    "df_circ_genes <- data.frame(circs = circs_com, genes = genes_com)\n",
    "\n",
    "\n",
    "physiological_paths <- read.table(\"/mnt/lustre/scratch/CBRA/research/projects/rrdd_mm/data/physiological_paths.tsv\", sep=\"\\t\") \n",
    "df_circ_physi_genes <- df_circ_genes[unlist(lapply(physiological_paths$V2, FUN=function(x) grep(x, df_circ_genes$circs))),]\n",
    "df_circ_physi_genes$circ_name <- get_path_names(pathways, df_circ_physi_genes$circs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8b14cb5d-8b9c-4f24-8e92-d5428ebdd25f",
   "metadata": {},
   "outputs": [],
   "source": [
    "saveRDS(df_circ_physi_genes, file=\"/mnt/lustre/scratch/CBRA/research/projects/tcga_mm/results/04_mm_ko_drug_used/circ_physi_genes.rds\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1e68f6fb-4225-4f2d-839f-6f541076130c",
   "metadata": {},
   "outputs": [],
   "source": [
    "### drugs and their target of drugbank"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "1d976304-4799-43f3-9236-2fca1e160a35",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_bank <- read.table(\"/mnt/lustre/scratch/CBRA/data/DRUGBANK/drugbank_drug-bindings_v5.1.8.tsv\", sep=\"\\t\", header=T)\n",
    "drug_bank_sel <- unique(drug_bank[,c(\"drug_name\",\"entrez_id\",\"actions\")])\n",
    "drug_bank_sel$drug_name <- tolower(drug_bank_sel$drug_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ade2f317-a7d4-4c01-b5ce-fef8df0d9390",
   "metadata": {},
   "outputs": [],
   "source": [
    "### projects of tcga selected"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "15f2b8ce-c9d7-4bfc-a812-682ca340f3b4",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<ol>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "\t<li>TRUE</li>\n",
       "</ol>\n"
      ],
      "text/latex": [
       "\\begin{enumerate}\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\item TRUE\n",
       "\\end{enumerate}\n"
      ],
      "text/markdown": [
       "1. TRUE\n",
       "2. TRUE\n",
       "3. TRUE\n",
       "4. TRUE\n",
       "5. TRUE\n",
       "6. TRUE\n",
       "7. TRUE\n",
       "8. TRUE\n",
       "9. TRUE\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       "[[1]]\n",
       "[1] TRUE\n",
       "\n",
       "[[2]]\n",
       "[1] TRUE\n",
       "\n",
       "[[3]]\n",
       "[1] TRUE\n",
       "\n",
       "[[4]]\n",
       "[1] TRUE\n",
       "\n",
       "[[5]]\n",
       "[1] TRUE\n",
       "\n",
       "[[6]]\n",
       "[1] TRUE\n",
       "\n",
       "[[7]]\n",
       "[1] TRUE\n",
       "\n",
       "[[8]]\n",
       "[1] TRUE\n",
       "\n",
       "[[9]]\n",
       "[1] TRUE\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "proj_tcga_sel <- c(\"tcga_brca\", \"tcga_coad\",\"tcga_esca\",\"tcga_lgg\",\"tcga_luad\",\"tcga_lusc\",\"tcga_paad\",\"tcga_skcm\",\"tcga_stad\")\n",
    "lapply(proj_tcga_sel, FUN=function(x) dir.create(paste(\"/mnt/lustre/scratch/CBRA/research/projects/tcga_mm/results/04_mm_ko_drug_used/04_2_pat_drug_db_circ/\",x, sep=\"\")))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5ca0a18f-fa16-4ea1-b6ed-3b3f982019d5",
   "metadata": {},
   "outputs": [],
   "source": [
    "### extract target of drug used in patients"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "7c69a593-9512-4d45-957a-24aa6199caa6",
   "metadata": {},
   "outputs": [],
   "source": [
    "funct_pat_drug_db_circ <- function(x){\n",
    "    file <- paste(\"/mnt/lustre/scratch/CBRA/research/projects/tcga_mm/results/04_mm_ko_drug_used/04_1_correc_drug/\",x,\"/pat_drug_corr_\",x,\".rds\",sep=\"\")\n",
    "    pat_drug_corr <- readRDS(file)\n",
    "\n",
    "    pat_drug_db <- drug_bank_sel[drug_bank_sel$drug_name %in% unique(pat_drug_corr$drug_name),]\n",
    "    pat_drug_db_circ <- merge(pat_drug_db, df_circ_physi_genes, by.x=\"entrez_id\",by.y=\"genes\")\n",
    "    fils <- paste(\"/mnt/lustre/scratch/CBRA/research/projects/tcga_mm/results/04_mm_ko_drug_used/04_2_pat_drug_db_circ/\",x,\"/pat_drug_db_circ_\",x,\".rds\",sep=\"\")\n",
    "    saveRDS(pat_drug_db_circ, file=fils)\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "ed61a140-5b29-46f6-a35f-6152eabdc81a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<ol>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "\t<li>NULL</li>\n",
       "</ol>\n"
      ],
      "text/latex": [
       "\\begin{enumerate}\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\item NULL\n",
       "\\end{enumerate}\n"
      ],
      "text/markdown": [
       "1. NULL\n",
       "2. NULL\n",
       "3. NULL\n",
       "4. NULL\n",
       "5. NULL\n",
       "6. NULL\n",
       "7. NULL\n",
       "8. NULL\n",
       "9. NULL\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       "[[1]]\n",
       "NULL\n",
       "\n",
       "[[2]]\n",
       "NULL\n",
       "\n",
       "[[3]]\n",
       "NULL\n",
       "\n",
       "[[4]]\n",
       "NULL\n",
       "\n",
       "[[5]]\n",
       "NULL\n",
       "\n",
       "[[6]]\n",
       "NULL\n",
       "\n",
       "[[7]]\n",
       "NULL\n",
       "\n",
       "[[8]]\n",
       "NULL\n",
       "\n",
       "[[9]]\n",
       "NULL\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "lapply(proj_tcga_sel, FUN=function(x) funct_pat_drug_db_circ(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "fd86921d-9ad6-4554-9003-c4921fb21371",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 8951 × 5</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>entrez_id</th><th scope=col>drug_name</th><th scope=col>actions</th><th scope=col>circs</th><th scope=col>circ_name</th></tr>\n",
       "\t<tr><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>  2</td><td>cisplatin     </td><td>NA       </td><td>P-hsa04610-57   </td><td>Complement and coagulation cascades: PLAUR </td></tr>\n",
       "\t<tr><td>  2</td><td>cisplatin     </td><td>NA       </td><td>P-hsa04610-17   </td><td>Complement and coagulation cascades: PLG   </td></tr>\n",
       "\t<tr><td>  2</td><td>cisplatin     </td><td>NA       </td><td>P-hsa04610-58   </td><td>Complement and coagulation cascades: F2RL2 </td></tr>\n",
       "\t<tr><td>  2</td><td>cisplatin     </td><td>NA       </td><td>P-hsa04610-11   </td><td>Complement and coagulation cascades: F2R   </td></tr>\n",
       "\t<tr><td>  2</td><td>cisplatin     </td><td>NA       </td><td>P-hsa04610-52   </td><td>Complement and coagulation cascades: CPB2  </td></tr>\n",
       "\t<tr><td>  2</td><td>cisplatin     </td><td>NA       </td><td>P-hsa04610-7    </td><td>Complement and coagulation cascades: Fibrin</td></tr>\n",
       "\t<tr><td>291</td><td>clodronic acid</td><td>inhibitor</td><td>P-hsa04022-71   </td><td>cGMP-PKG signaling pathway: PPIF           </td></tr>\n",
       "\t<tr><td>292</td><td>clodronic acid</td><td>inhibitor</td><td>P-hsa04022-71   </td><td>cGMP-PKG signaling pathway: PPIF           </td></tr>\n",
       "\t<tr><td>293</td><td>clodronic acid</td><td>inhibitor</td><td>P-hsa04022-71   </td><td>cGMP-PKG signaling pathway: PPIF           </td></tr>\n",
       "\t<tr><td>316</td><td>methotrexate  </td><td>substrate</td><td>P-hsa04630-34   </td><td>Jak-STAT signaling pathway: AOX1           </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04210-75   </td><td>Apoptosis: BAK1*                           </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04151-96   </td><td>PI3K-Akt signaling pathway: BCL2           </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04210-74   </td><td>Apoptosis: BAX*                            </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04340-50   </td><td>Hedgehog signaling pathway: BCL2           </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04510-44   </td><td>Focal adhesion: BCL2                       </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04064-3    </td><td>NF-kappa B signaling pathway: BCL2         </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04210-119  </td><td>Apoptosis: BCL2*                           </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04066-88   </td><td>HIF-1 signaling pathway: BCL2              </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04071-59 60</td><td>Sphingolipid signaling pathway: TP53 BCL2  </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04340-52   </td><td>Hedgehog signaling pathway: BCL2*          </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04630-7    </td><td>Jak-STAT signaling pathway: BCL2           </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04151-103  </td><td>PI3K-Akt signaling pathway: BCL2*          </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04725-50   </td><td>Cholinergic synapse: BCL2                  </td></tr>\n",
       "\t<tr><td>596</td><td>paclitaxel    </td><td>inhibitor</td><td>P-hsa04151-110  </td><td>PI3K-Akt signaling pathway: BCL2**         </td></tr>\n",
       "\t<tr><td>596</td><td>docetaxel     </td><td>NA       </td><td>P-hsa04210-75   </td><td>Apoptosis: BAK1*                           </td></tr>\n",
       "\t<tr><td>596</td><td>docetaxel     </td><td>NA       </td><td>P-hsa04151-96   </td><td>PI3K-Akt signaling pathway: BCL2           </td></tr>\n",
       "\t<tr><td>596</td><td>docetaxel     </td><td>NA       </td><td>P-hsa04210-74   </td><td>Apoptosis: BAX*                            </td></tr>\n",
       "\t<tr><td>596</td><td>docetaxel     </td><td>NA       </td><td>P-hsa04340-50   </td><td>Hedgehog signaling pathway: BCL2           </td></tr>\n",
       "\t<tr><td>596</td><td>docetaxel     </td><td>NA       </td><td>P-hsa04510-44   </td><td>Focal adhesion: BCL2                       </td></tr>\n",
       "\t<tr><td>596</td><td>docetaxel     </td><td>NA       </td><td>P-hsa04064-3    </td><td>NF-kappa B signaling pathway: BCL2         </td></tr>\n",
       "\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04913-64 </td><td>Ovarian steroidogenesis: PLA2G4B                              </td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04370-15 </td><td>VEGF signaling pathway: PLA2G4B                               </td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04750-53 </td><td>Inflammatory mediator regulation of TRP channels: TRPM8       </td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04664-46 </td><td>Fc epsilon RI signaling pathway: PLA2G4B                      </td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04014-42 </td><td>Ras signaling pathway: PLA2G4B                                </td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04270-28 </td><td>Vascular smooth muscle contraction: KCNMB2                    </td></tr>\n",
       "\t<tr><td> 5321</td><td>epirubicin </td><td>inhibitor</td><td>P-hsa04750-40 </td><td>Inflammatory mediator regulation of TRP channels: Arachidonate</td></tr>\n",
       "\t<tr><td> 5742</td><td>etoposide  </td><td>substrate</td><td>P-hsa04611-34 </td><td>Platelet activation: Thromboxane A2*                          </td></tr>\n",
       "\t<tr><td> 5742</td><td>etoposide  </td><td>substrate</td><td>P-hsa04726-10 </td><td>Serotonergic synapse: PRKACA                                  </td></tr>\n",
       "\t<tr><td> 5743</td><td>etoposide  </td><td>substrate</td><td>P-hsa04921-41 </td><td>Oxytocin signaling pathway: PTGS2                             </td></tr>\n",
       "\t<tr><td> 5743</td><td>etoposide  </td><td>substrate</td><td>P-hsa04921-55 </td><td>Oxytocin signaling pathway: PTGS2*                            </td></tr>\n",
       "\t<tr><td> 5743</td><td>etoposide  </td><td>substrate</td><td>P-hsa04064-129</td><td>NF-kappa B signaling pathway: PTGS2                           </td></tr>\n",
       "\t<tr><td> 5743</td><td>etoposide  </td><td>substrate</td><td>P-hsa04370-14 </td><td>VEGF signaling pathway: PTGS2                                 </td></tr>\n",
       "\t<tr><td> 5743</td><td>etoposide  </td><td>substrate</td><td>P-hsa04726-10 </td><td>Serotonergic synapse: PRKACA                                  </td></tr>\n",
       "\t<tr><td> 5743</td><td>cisplatin  </td><td>inhibitor</td><td>P-hsa04921-41 </td><td>Oxytocin signaling pathway: PTGS2                             </td></tr>\n",
       "\t<tr><td> 5743</td><td>cisplatin  </td><td>inhibitor</td><td>P-hsa04921-55 </td><td>Oxytocin signaling pathway: PTGS2*                            </td></tr>\n",
       "\t<tr><td> 5743</td><td>cisplatin  </td><td>inhibitor</td><td>P-hsa04064-129</td><td>NF-kappa B signaling pathway: PTGS2                           </td></tr>\n",
       "\t<tr><td> 5743</td><td>cisplatin  </td><td>inhibitor</td><td>P-hsa04370-14 </td><td>VEGF signaling pathway: PTGS2                                 </td></tr>\n",
       "\t<tr><td> 5743</td><td>cisplatin  </td><td>inhibitor</td><td>P-hsa04726-10 </td><td>Serotonergic synapse: PRKACA                                  </td></tr>\n",
       "\t<tr><td> 7018</td><td>cisplatin  </td><td>NA       </td><td>P-hsa04066-50 </td><td>HIF-1 signaling pathway: TF                                   </td></tr>\n",
       "\t<tr><td> 7277</td><td>vincristine</td><td>inhibitor</td><td>P-hsa04210-106</td><td>Apoptosis: TUBA1B                                             </td></tr>\n",
       "\t<tr><td> 8644</td><td>doxorubicin</td><td>substrate</td><td>P-hsa04913-35 </td><td>Ovarian steroidogenesis: HSD17B2                              </td></tr>\n",
       "\t<tr><td>10928</td><td>vincristine</td><td>substrate</td><td>P-hsa04014-79 </td><td>Ras signaling pathway: RAC1**                                 </td></tr>\n",
       "\t<tr><td>10928</td><td>vincristine</td><td>substrate</td><td>P-hsa04014-76 </td><td>Ras signaling pathway: RALBP1*                                </td></tr>\n",
       "\t<tr><td>10928</td><td>vincristine</td><td>substrate</td><td>P-hsa04014-41 </td><td>Ras signaling pathway: RAC1*                                  </td></tr>\n",
       "\t<tr><td>10928</td><td>vincristine</td><td>substrate</td><td>P-hsa04014-38 </td><td>Ras signaling pathway: MAPK8                                  </td></tr>\n",
       "\t<tr><td>10928</td><td>doxorubicin</td><td>substrate</td><td>P-hsa04014-79 </td><td>Ras signaling pathway: RAC1**                                 </td></tr>\n",
       "\t<tr><td>10928</td><td>doxorubicin</td><td>substrate</td><td>P-hsa04014-76 </td><td>Ras signaling pathway: RALBP1*                                </td></tr>\n",
       "\t<tr><td>10928</td><td>doxorubicin</td><td>substrate</td><td>P-hsa04014-41 </td><td>Ras signaling pathway: RAC1*                                  </td></tr>\n",
       "\t<tr><td>10928</td><td>doxorubicin</td><td>substrate</td><td>P-hsa04014-38 </td><td>Ras signaling pathway: MAPK8                                  </td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 8951 × 5\n",
       "\\begin{tabular}{lllll}\n",
       " entrez\\_id & drug\\_name & actions & circs & circ\\_name\\\\\n",
       " <int> & <chr> & <chr> & <chr> & <chr>\\\\\n",
       "\\hline\n",
       "\t   2 & cisplatin      & NA        & P-hsa04610-57    & Complement and coagulation cascades: PLAUR \\\\\n",
       "\t   2 & cisplatin      & NA        & P-hsa04610-17    & Complement and coagulation cascades: PLG   \\\\\n",
       "\t   2 & cisplatin      & NA        & P-hsa04610-58    & Complement and coagulation cascades: F2RL2 \\\\\n",
       "\t   2 & cisplatin      & NA        & P-hsa04610-11    & Complement and coagulation cascades: F2R   \\\\\n",
       "\t   2 & cisplatin      & NA        & P-hsa04610-52    & Complement and coagulation cascades: CPB2  \\\\\n",
       "\t   2 & cisplatin      & NA        & P-hsa04610-7     & Complement and coagulation cascades: Fibrin\\\\\n",
       "\t 291 & clodronic acid & inhibitor & P-hsa04022-71    & cGMP-PKG signaling pathway: PPIF           \\\\\n",
       "\t 292 & clodronic acid & inhibitor & P-hsa04022-71    & cGMP-PKG signaling pathway: PPIF           \\\\\n",
       "\t 293 & clodronic acid & inhibitor & P-hsa04022-71    & cGMP-PKG signaling pathway: PPIF           \\\\\n",
       "\t 316 & methotrexate   & substrate & P-hsa04630-34    & Jak-STAT signaling pathway: AOX1           \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04210-75    & Apoptosis: BAK1*                           \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04151-96    & PI3K-Akt signaling pathway: BCL2           \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04210-74    & Apoptosis: BAX*                            \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04340-50    & Hedgehog signaling pathway: BCL2           \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04510-44    & Focal adhesion: BCL2                       \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04064-3     & NF-kappa B signaling pathway: BCL2         \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04210-119   & Apoptosis: BCL2*                           \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04066-88    & HIF-1 signaling pathway: BCL2              \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04071-59 60 & Sphingolipid signaling pathway: TP53 BCL2  \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04340-52    & Hedgehog signaling pathway: BCL2*          \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04630-7     & Jak-STAT signaling pathway: BCL2           \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04151-103   & PI3K-Akt signaling pathway: BCL2*          \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04725-50    & Cholinergic synapse: BCL2                  \\\\\n",
       "\t 596 & paclitaxel     & inhibitor & P-hsa04151-110   & PI3K-Akt signaling pathway: BCL2**         \\\\\n",
       "\t 596 & docetaxel      & NA        & P-hsa04210-75    & Apoptosis: BAK1*                           \\\\\n",
       "\t 596 & docetaxel      & NA        & P-hsa04151-96    & PI3K-Akt signaling pathway: BCL2           \\\\\n",
       "\t 596 & docetaxel      & NA        & P-hsa04210-74    & Apoptosis: BAX*                            \\\\\n",
       "\t 596 & docetaxel      & NA        & P-hsa04340-50    & Hedgehog signaling pathway: BCL2           \\\\\n",
       "\t 596 & docetaxel      & NA        & P-hsa04510-44    & Focal adhesion: BCL2                       \\\\\n",
       "\t 596 & docetaxel      & NA        & P-hsa04064-3     & NF-kappa B signaling pathway: BCL2         \\\\\n",
       "\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04913-64  & Ovarian steroidogenesis: PLA2G4B                              \\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04370-15  & VEGF signaling pathway: PLA2G4B                               \\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04750-53  & Inflammatory mediator regulation of TRP channels: TRPM8       \\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04664-46  & Fc epsilon RI signaling pathway: PLA2G4B                      \\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04014-42  & Ras signaling pathway: PLA2G4B                                \\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04270-28  & Vascular smooth muscle contraction: KCNMB2                    \\\\\n",
       "\t  5321 & epirubicin  & inhibitor & P-hsa04750-40  & Inflammatory mediator regulation of TRP channels: Arachidonate\\\\\n",
       "\t  5742 & etoposide   & substrate & P-hsa04611-34  & Platelet activation: Thromboxane A2*                          \\\\\n",
       "\t  5742 & etoposide   & substrate & P-hsa04726-10  & Serotonergic synapse: PRKACA                                  \\\\\n",
       "\t  5743 & etoposide   & substrate & P-hsa04921-41  & Oxytocin signaling pathway: PTGS2                             \\\\\n",
       "\t  5743 & etoposide   & substrate & P-hsa04921-55  & Oxytocin signaling pathway: PTGS2*                            \\\\\n",
       "\t  5743 & etoposide   & substrate & P-hsa04064-129 & NF-kappa B signaling pathway: PTGS2                           \\\\\n",
       "\t  5743 & etoposide   & substrate & P-hsa04370-14  & VEGF signaling pathway: PTGS2                                 \\\\\n",
       "\t  5743 & etoposide   & substrate & P-hsa04726-10  & Serotonergic synapse: PRKACA                                  \\\\\n",
       "\t  5743 & cisplatin   & inhibitor & P-hsa04921-41  & Oxytocin signaling pathway: PTGS2                             \\\\\n",
       "\t  5743 & cisplatin   & inhibitor & P-hsa04921-55  & Oxytocin signaling pathway: PTGS2*                            \\\\\n",
       "\t  5743 & cisplatin   & inhibitor & P-hsa04064-129 & NF-kappa B signaling pathway: PTGS2                           \\\\\n",
       "\t  5743 & cisplatin   & inhibitor & P-hsa04370-14  & VEGF signaling pathway: PTGS2                                 \\\\\n",
       "\t  5743 & cisplatin   & inhibitor & P-hsa04726-10  & Serotonergic synapse: PRKACA                                  \\\\\n",
       "\t  7018 & cisplatin   & NA        & P-hsa04066-50  & HIF-1 signaling pathway: TF                                   \\\\\n",
       "\t  7277 & vincristine & inhibitor & P-hsa04210-106 & Apoptosis: TUBA1B                                             \\\\\n",
       "\t  8644 & doxorubicin & substrate & P-hsa04913-35  & Ovarian steroidogenesis: HSD17B2                              \\\\\n",
       "\t 10928 & vincristine & substrate & P-hsa04014-79  & Ras signaling pathway: RAC1**                                 \\\\\n",
       "\t 10928 & vincristine & substrate & P-hsa04014-76  & Ras signaling pathway: RALBP1*                                \\\\\n",
       "\t 10928 & vincristine & substrate & P-hsa04014-41  & Ras signaling pathway: RAC1*                                  \\\\\n",
       "\t 10928 & vincristine & substrate & P-hsa04014-38  & Ras signaling pathway: MAPK8                                  \\\\\n",
       "\t 10928 & doxorubicin & substrate & P-hsa04014-79  & Ras signaling pathway: RAC1**                                 \\\\\n",
       "\t 10928 & doxorubicin & substrate & P-hsa04014-76  & Ras signaling pathway: RALBP1*                                \\\\\n",
       "\t 10928 & doxorubicin & substrate & P-hsa04014-41  & Ras signaling pathway: RAC1*                                  \\\\\n",
       "\t 10928 & doxorubicin & substrate & P-hsa04014-38  & Ras signaling pathway: MAPK8                                  \\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 8951 × 5\n",
       "\n",
       "| entrez_id &lt;int&gt; | drug_name &lt;chr&gt; | actions &lt;chr&gt; | circs &lt;chr&gt; | circ_name &lt;chr&gt; |\n",
       "|---|---|---|---|---|\n",
       "|   2 | cisplatin      | NA        | P-hsa04610-57    | Complement and coagulation cascades: PLAUR  |\n",
       "|   2 | cisplatin      | NA        | P-hsa04610-17    | Complement and coagulation cascades: PLG    |\n",
       "|   2 | cisplatin      | NA        | P-hsa04610-58    | Complement and coagulation cascades: F2RL2  |\n",
       "|   2 | cisplatin      | NA        | P-hsa04610-11    | Complement and coagulation cascades: F2R    |\n",
       "|   2 | cisplatin      | NA        | P-hsa04610-52    | Complement and coagulation cascades: CPB2   |\n",
       "|   2 | cisplatin      | NA        | P-hsa04610-7     | Complement and coagulation cascades: Fibrin |\n",
       "| 291 | clodronic acid | inhibitor | P-hsa04022-71    | cGMP-PKG signaling pathway: PPIF            |\n",
       "| 292 | clodronic acid | inhibitor | P-hsa04022-71    | cGMP-PKG signaling pathway: PPIF            |\n",
       "| 293 | clodronic acid | inhibitor | P-hsa04022-71    | cGMP-PKG signaling pathway: PPIF            |\n",
       "| 316 | methotrexate   | substrate | P-hsa04630-34    | Jak-STAT signaling pathway: AOX1            |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04210-75    | Apoptosis: BAK1*                            |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04151-96    | PI3K-Akt signaling pathway: BCL2            |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04210-74    | Apoptosis: BAX*                             |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04340-50    | Hedgehog signaling pathway: BCL2            |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04510-44    | Focal adhesion: BCL2                        |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04064-3     | NF-kappa B signaling pathway: BCL2          |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04210-119   | Apoptosis: BCL2*                            |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04066-88    | HIF-1 signaling pathway: BCL2               |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04071-59 60 | Sphingolipid signaling pathway: TP53 BCL2   |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04340-52    | Hedgehog signaling pathway: BCL2*           |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04630-7     | Jak-STAT signaling pathway: BCL2            |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04151-103   | PI3K-Akt signaling pathway: BCL2*           |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04725-50    | Cholinergic synapse: BCL2                   |\n",
       "| 596 | paclitaxel     | inhibitor | P-hsa04151-110   | PI3K-Akt signaling pathway: BCL2**          |\n",
       "| 596 | docetaxel      | NA        | P-hsa04210-75    | Apoptosis: BAK1*                            |\n",
       "| 596 | docetaxel      | NA        | P-hsa04151-96    | PI3K-Akt signaling pathway: BCL2            |\n",
       "| 596 | docetaxel      | NA        | P-hsa04210-74    | Apoptosis: BAX*                             |\n",
       "| 596 | docetaxel      | NA        | P-hsa04340-50    | Hedgehog signaling pathway: BCL2            |\n",
       "| 596 | docetaxel      | NA        | P-hsa04510-44    | Focal adhesion: BCL2                        |\n",
       "| 596 | docetaxel      | NA        | P-hsa04064-3     | NF-kappa B signaling pathway: BCL2          |\n",
       "| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04913-64  | Ovarian steroidogenesis: PLA2G4B                               |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04370-15  | VEGF signaling pathway: PLA2G4B                                |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04750-53  | Inflammatory mediator regulation of TRP channels: TRPM8        |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04664-46  | Fc epsilon RI signaling pathway: PLA2G4B                       |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04014-42  | Ras signaling pathway: PLA2G4B                                 |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04270-28  | Vascular smooth muscle contraction: KCNMB2                     |\n",
       "|  5321 | epirubicin  | inhibitor | P-hsa04750-40  | Inflammatory mediator regulation of TRP channels: Arachidonate |\n",
       "|  5742 | etoposide   | substrate | P-hsa04611-34  | Platelet activation: Thromboxane A2*                           |\n",
       "|  5742 | etoposide   | substrate | P-hsa04726-10  | Serotonergic synapse: PRKACA                                   |\n",
       "|  5743 | etoposide   | substrate | P-hsa04921-41  | Oxytocin signaling pathway: PTGS2                              |\n",
       "|  5743 | etoposide   | substrate | P-hsa04921-55  | Oxytocin signaling pathway: PTGS2*                             |\n",
       "|  5743 | etoposide   | substrate | P-hsa04064-129 | NF-kappa B signaling pathway: PTGS2                            |\n",
       "|  5743 | etoposide   | substrate | P-hsa04370-14  | VEGF signaling pathway: PTGS2                                  |\n",
       "|  5743 | etoposide   | substrate | P-hsa04726-10  | Serotonergic synapse: PRKACA                                   |\n",
       "|  5743 | cisplatin   | inhibitor | P-hsa04921-41  | Oxytocin signaling pathway: PTGS2                              |\n",
       "|  5743 | cisplatin   | inhibitor | P-hsa04921-55  | Oxytocin signaling pathway: PTGS2*                             |\n",
       "|  5743 | cisplatin   | inhibitor | P-hsa04064-129 | NF-kappa B signaling pathway: PTGS2                            |\n",
       "|  5743 | cisplatin   | inhibitor | P-hsa04370-14  | VEGF signaling pathway: PTGS2                                  |\n",
       "|  5743 | cisplatin   | inhibitor | P-hsa04726-10  | Serotonergic synapse: PRKACA                                   |\n",
       "|  7018 | cisplatin   | NA        | P-hsa04066-50  | HIF-1 signaling pathway: TF                                    |\n",
       "|  7277 | vincristine | inhibitor | P-hsa04210-106 | Apoptosis: TUBA1B                                              |\n",
       "|  8644 | doxorubicin | substrate | P-hsa04913-35  | Ovarian steroidogenesis: HSD17B2                               |\n",
       "| 10928 | vincristine | substrate | P-hsa04014-79  | Ras signaling pathway: RAC1**                                  |\n",
       "| 10928 | vincristine | substrate | P-hsa04014-76  | Ras signaling pathway: RALBP1*                                 |\n",
       "| 10928 | vincristine | substrate | P-hsa04014-41  | Ras signaling pathway: RAC1*                                   |\n",
       "| 10928 | vincristine | substrate | P-hsa04014-38  | Ras signaling pathway: MAPK8                                   |\n",
       "| 10928 | doxorubicin | substrate | P-hsa04014-79  | Ras signaling pathway: RAC1**                                  |\n",
       "| 10928 | doxorubicin | substrate | P-hsa04014-76  | Ras signaling pathway: RALBP1*                                 |\n",
       "| 10928 | doxorubicin | substrate | P-hsa04014-41  | Ras signaling pathway: RAC1*                                   |\n",
       "| 10928 | doxorubicin | substrate | P-hsa04014-38  | Ras signaling pathway: MAPK8                                   |\n",
       "\n"
      ],
      "text/plain": [
       "     entrez_id drug_name      actions   circs           \n",
       "1      2       cisplatin      NA        P-hsa04610-57   \n",
       "2      2       cisplatin      NA        P-hsa04610-17   \n",
       "3      2       cisplatin      NA        P-hsa04610-58   \n",
       "4      2       cisplatin      NA        P-hsa04610-11   \n",
       "5      2       cisplatin      NA        P-hsa04610-52   \n",
       "6      2       cisplatin      NA        P-hsa04610-7    \n",
       "7    291       clodronic acid inhibitor P-hsa04022-71   \n",
       "8    292       clodronic acid inhibitor P-hsa04022-71   \n",
       "9    293       clodronic acid inhibitor P-hsa04022-71   \n",
       "10   316       methotrexate   substrate P-hsa04630-34   \n",
       "11   596       paclitaxel     inhibitor P-hsa04210-75   \n",
       "12   596       paclitaxel     inhibitor P-hsa04151-96   \n",
       "13   596       paclitaxel     inhibitor P-hsa04210-74   \n",
       "14   596       paclitaxel     inhibitor P-hsa04340-50   \n",
       "15   596       paclitaxel     inhibitor P-hsa04510-44   \n",
       "16   596       paclitaxel     inhibitor P-hsa04064-3    \n",
       "17   596       paclitaxel     inhibitor P-hsa04210-119  \n",
       "18   596       paclitaxel     inhibitor P-hsa04066-88   \n",
       "19   596       paclitaxel     inhibitor P-hsa04071-59 60\n",
       "20   596       paclitaxel     inhibitor P-hsa04340-52   \n",
       "21   596       paclitaxel     inhibitor P-hsa04630-7    \n",
       "22   596       paclitaxel     inhibitor P-hsa04151-103  \n",
       "23   596       paclitaxel     inhibitor P-hsa04725-50   \n",
       "24   596       paclitaxel     inhibitor P-hsa04151-110  \n",
       "25   596       docetaxel      NA        P-hsa04210-75   \n",
       "26   596       docetaxel      NA        P-hsa04151-96   \n",
       "27   596       docetaxel      NA        P-hsa04210-74   \n",
       "28   596       docetaxel      NA        P-hsa04340-50   \n",
       "29   596       docetaxel      NA        P-hsa04510-44   \n",
       "30   596       docetaxel      NA        P-hsa04064-3    \n",
       "⋮    ⋮         ⋮              ⋮         ⋮               \n",
       "8922  5321     epirubicin     inhibitor P-hsa04913-64   \n",
       "8923  5321     epirubicin     inhibitor P-hsa04370-15   \n",
       "8924  5321     epirubicin     inhibitor P-hsa04750-53   \n",
       "8925  5321     epirubicin     inhibitor P-hsa04664-46   \n",
       "8926  5321     epirubicin     inhibitor P-hsa04014-42   \n",
       "8927  5321     epirubicin     inhibitor P-hsa04270-28   \n",
       "8928  5321     epirubicin     inhibitor P-hsa04750-40   \n",
       "8929  5742     etoposide      substrate P-hsa04611-34   \n",
       "8930  5742     etoposide      substrate P-hsa04726-10   \n",
       "8931  5743     etoposide      substrate P-hsa04921-41   \n",
       "8932  5743     etoposide      substrate P-hsa04921-55   \n",
       "8933  5743     etoposide      substrate P-hsa04064-129  \n",
       "8934  5743     etoposide      substrate P-hsa04370-14   \n",
       "8935  5743     etoposide      substrate P-hsa04726-10   \n",
       "8936  5743     cisplatin      inhibitor P-hsa04921-41   \n",
       "8937  5743     cisplatin      inhibitor P-hsa04921-55   \n",
       "8938  5743     cisplatin      inhibitor P-hsa04064-129  \n",
       "8939  5743     cisplatin      inhibitor P-hsa04370-14   \n",
       "8940  5743     cisplatin      inhibitor P-hsa04726-10   \n",
       "8941  7018     cisplatin      NA        P-hsa04066-50   \n",
       "8942  7277     vincristine    inhibitor P-hsa04210-106  \n",
       "8943  8644     doxorubicin    substrate P-hsa04913-35   \n",
       "8944 10928     vincristine    substrate P-hsa04014-79   \n",
       "8945 10928     vincristine    substrate P-hsa04014-76   \n",
       "8946 10928     vincristine    substrate P-hsa04014-41   \n",
       "8947 10928     vincristine    substrate P-hsa04014-38   \n",
       "8948 10928     doxorubicin    substrate P-hsa04014-79   \n",
       "8949 10928     doxorubicin    substrate P-hsa04014-76   \n",
       "8950 10928     doxorubicin    substrate P-hsa04014-41   \n",
       "8951 10928     doxorubicin    substrate P-hsa04014-38   \n",
       "     circ_name                                                     \n",
       "1    Complement and coagulation cascades: PLAUR                    \n",
       "2    Complement and coagulation cascades: PLG                      \n",
       "3    Complement and coagulation cascades: F2RL2                    \n",
       "4    Complement and coagulation cascades: F2R                      \n",
       "5    Complement and coagulation cascades: CPB2                     \n",
       "6    Complement and coagulation cascades: Fibrin                   \n",
       "7    cGMP-PKG signaling pathway: PPIF                              \n",
       "8    cGMP-PKG signaling pathway: PPIF                              \n",
       "9    cGMP-PKG signaling pathway: PPIF                              \n",
       "10   Jak-STAT signaling pathway: AOX1                              \n",
       "11   Apoptosis: BAK1*                                              \n",
       "12   PI3K-Akt signaling pathway: BCL2                              \n",
       "13   Apoptosis: BAX*                                               \n",
       "14   Hedgehog signaling pathway: BCL2                              \n",
       "15   Focal adhesion: BCL2                                          \n",
       "16   NF-kappa B signaling pathway: BCL2                            \n",
       "17   Apoptosis: BCL2*                                              \n",
       "18   HIF-1 signaling pathway: BCL2                                 \n",
       "19   Sphingolipid signaling pathway: TP53 BCL2                     \n",
       "20   Hedgehog signaling pathway: BCL2*                             \n",
       "21   Jak-STAT signaling pathway: BCL2                              \n",
       "22   PI3K-Akt signaling pathway: BCL2*                             \n",
       "23   Cholinergic synapse: BCL2                                     \n",
       "24   PI3K-Akt signaling pathway: BCL2**                            \n",
       "25   Apoptosis: BAK1*                                              \n",
       "26   PI3K-Akt signaling pathway: BCL2                              \n",
       "27   Apoptosis: BAX*                                               \n",
       "28   Hedgehog signaling pathway: BCL2                              \n",
       "29   Focal adhesion: BCL2                                          \n",
       "30   NF-kappa B signaling pathway: BCL2                            \n",
       "⋮    ⋮                                                             \n",
       "8922 Ovarian steroidogenesis: PLA2G4B                              \n",
       "8923 VEGF signaling pathway: PLA2G4B                               \n",
       "8924 Inflammatory mediator regulation of TRP channels: TRPM8       \n",
       "8925 Fc epsilon RI signaling pathway: PLA2G4B                      \n",
       "8926 Ras signaling pathway: PLA2G4B                                \n",
       "8927 Vascular smooth muscle contraction: KCNMB2                    \n",
       "8928 Inflammatory mediator regulation of TRP channels: Arachidonate\n",
       "8929 Platelet activation: Thromboxane A2*                          \n",
       "8930 Serotonergic synapse: PRKACA                                  \n",
       "8931 Oxytocin signaling pathway: PTGS2                             \n",
       "8932 Oxytocin signaling pathway: PTGS2*                            \n",
       "8933 NF-kappa B signaling pathway: PTGS2                           \n",
       "8934 VEGF signaling pathway: PTGS2                                 \n",
       "8935 Serotonergic synapse: PRKACA                                  \n",
       "8936 Oxytocin signaling pathway: PTGS2                             \n",
       "8937 Oxytocin signaling pathway: PTGS2*                            \n",
       "8938 NF-kappa B signaling pathway: PTGS2                           \n",
       "8939 VEGF signaling pathway: PTGS2                                 \n",
       "8940 Serotonergic synapse: PRKACA                                  \n",
       "8941 HIF-1 signaling pathway: TF                                   \n",
       "8942 Apoptosis: TUBA1B                                             \n",
       "8943 Ovarian steroidogenesis: HSD17B2                              \n",
       "8944 Ras signaling pathway: RAC1**                                 \n",
       "8945 Ras signaling pathway: RALBP1*                                \n",
       "8946 Ras signaling pathway: RAC1*                                  \n",
       "8947 Ras signaling pathway: MAPK8                                  \n",
       "8948 Ras signaling pathway: RAC1**                                 \n",
       "8949 Ras signaling pathway: RALBP1*                                \n",
       "8950 Ras signaling pathway: RAC1*                                  \n",
       "8951 Ras signaling pathway: MAPK8                                  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "p"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "f90ac37c-7495-445b-af75-aba7a79d4fa9",
   "metadata": {},
   "outputs": [],
   "source": [
    "proj_tcga_sel <- c(\"tcga_brca\", \"tcga_coad\",\"tcga_esca\",\"tcga_lgg\",\"tcga_luad\",\"tcga_lusc\",\"tcga_paad\",\"tcga_skcm\",\"tcga_stad\")\n",
    "\n",
    "get <- function(x){\n",
    "    fils <- paste(\"/mnt/lustre/scratch/CBRA/research/projects/tcga_mm/results/04_mm_ko_drug_used/04_2_pat_drug_db_circ/\",x,\"/pat_drug_db_circ_\",x,\".rds\",sep=\"\")\n",
    "    file <- readRDS(fils)\n",
    "    file$project <- rep(x, length(file$actions))\n",
    "    return(file)\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "9588f809-9bf1-423f-833f-ea75c97afc79",
   "metadata": {},
   "outputs": [],
   "source": [
    "get_drug_actions <- do.call(rbind,lapply(proj_tcga_sel, FUN=function(x) get(x)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "8186572e-7bae-48fe-af99-d07850fe4383",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A data.frame: 2 × 2</caption>\n",
       "<thead>\n",
       "\t<tr><th></th><th scope=col>entrez_id</th><th scope=col>project</th></tr>\n",
       "\t<tr><th></th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><th scope=row>1</th><td>5564</td><td>tcga_brca</td></tr>\n",
       "\t<tr><th scope=row>76</th><td>1441</td><td>tcga_coad</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A data.frame: 2 × 2\n",
       "\\begin{tabular}{r|ll}\n",
       "  & entrez\\_id & project\\\\\n",
       "  & <int> & <chr>\\\\\n",
       "\\hline\n",
       "\t1 & 5564 & tcga\\_brca\\\\\n",
       "\t76 & 1441 & tcga\\_coad\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A data.frame: 2 × 2\n",
       "\n",
       "| <!--/--> | entrez_id &lt;int&gt; | project &lt;chr&gt; |\n",
       "|---|---|---|\n",
       "| 1 | 5564 | tcga_brca |\n",
       "| 76 | 1441 | tcga_coad |\n",
       "\n"
      ],
      "text/plain": [
       "   entrez_id project  \n",
       "1  5564      tcga_brca\n",
       "76 1441      tcga_coad"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "unique(data.frame(get_drug_actions %>% filter(actions == \"inducer,activator\" | actions == \"stimulator\"))[,c(\"entrez_id\",\"project\")])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8cd49099-8123-4db6-9421-eeb37834e206",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "R",
   "language": "R",
   "name": "ir"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "4.3.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
